Rare diseases
Investigational molecules
Locations
Study of MK-7684A and Pembrolizumab for Patients with Advanced Solid Tumors
FranceStudy of TransCon TLR7/8 Agonist, TransCon IL-2 β/γ, and Pembrolizumab for Patients with Advanced Head and Neck Cancer
GermanyStudy on IO102-IO103 and Pembrolizumab for Patients with Metastatic Lung, Head and Neck, or Bladder Cancer
SpainStudy of Tisotumab Vedotin, Pembrolizumab, and Platinum Drug Combination for Patients with Advanced or Metastatic Solid Tumors
FranceStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
BelgiumStudy on the Safety and Effectiveness of Pembrolizumab and Drug Combination for Patients with Stage III Melanoma Eligible for Neoadjuvant Therapy
FranceStudy on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma
FranceStudy Comparing Dostarlimab and Pembrolizumab with Chemotherapy for Patients with Metastatic Non-Small Cell Lung Cancer
FranceStudy of E7386 and Pembrolizumab for Patients with Previously Treated Colorectal Cancer, Melanoma, or Hepatocellular Carcinoma
SpainStudy of Pembrolizumab for Patients with Locally Advanced, Unresectable, Non-Metastatic Colorectal Cancer
The NetherlandsStudy of pembrolizumab and vorinostat combination therapy in patients with recurrent or metastatic squamous cell carcinoma of head and neck, cervix, anus, and genital areas
FranceStudy of Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Renal Cell Carcinoma
FranceTell us about your condition – we search every trial in Europe and connect you with the right site.
